{"transactions":[{"id":761468,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-27T21:10:03.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":11876,"price":54.5518,"value":647857.1768,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $54.315 to $55.08 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transaction includes 41,480 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":41480,"source":{"system":"sec-edgar","filing":"0001193125-26-242141","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312526242141/ownership.xml","form_type":"4"}},{"id":964631,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2025-12-18T02:44:30.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":5233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 8,094 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 5,233 PSUs. The remaining 2,861 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 8,094 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 64.65% of the target award amount resulting in the vesting of 5,233 PSUs. The remaining 2,861 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5233},"source":{"system":"sec-edgar","filing":"0001193125-25-323435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323435/ownership.xml","form_type":"4"}},{"id":964630,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-18T02:44:30.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":41500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option was granted for a total of 41,500 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2025, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":41500,"derivative":{"exercise_price":66.62,"expiration_date":"2035-12-15","underlying":"Class A Common Stock","underlying_shares":41500},"source":{"system":"sec-edgar","filing":"0001193125-25-323435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323435/ownership.xml","form_type":"4"}},{"id":964629,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2025-12-18T02:44:30.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":9424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each performance-based restricted stock unit (\"PSU\") represents a right to receive, upon vesting, one share of Class A common stock. The vesting of this PSU award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2025 and ending December 12, 2028 and (ii) satisfaction of a service-based vesting component. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon the later of three years from the date of grant and certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":9424,"derivative":{"underlying":"Class A Common Stock","underlying_shares":9424},"source":{"system":"sec-edgar","filing":"0001193125-25-323435","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323435/ownership.xml","form_type":"4"}},{"id":964628,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-18T02:44:30.000Z","date":"2025-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1959,"price":66.62,"value":130508.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 41,480 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":53356,"source":{"system":"sec-edgar","filing":"0001193125-25-323435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323435/ownership.xml","form_type":"4"}},{"id":964627,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-18T02:44:30.000Z","date":"2025-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6056,"price":67.54,"value":409022.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 45,367 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":55315,"source":{"system":"sec-edgar","filing":"0001193125-25-323435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323435/ownership.xml","form_type":"4"}},{"id":964626,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-18T02:44:30.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":5233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 56,138 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":61371,"source":{"system":"sec-edgar","filing":"0001193125-25-323435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323435/ownership.xml","form_type":"4"}},{"id":964625,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2025-12-18T02:44:30.000Z","date":"2025-12-15","kind":"grant","planned":false,"acquired":true,"shares":18848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 18,848 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2025. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 56,138 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":56138,"source":{"system":"sec-edgar","filing":"0001193125-25-323435","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000119312525323435/ownership.xml","form_type":"4"}},{"id":1252474,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-21T22:17:52.000Z","date":"2025-02-19","kind":"exercise","planned":false,"acquired":false,"shares":7286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 29,143 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":13358,"derivative":{"exercise_price":71.07,"expiration_date":"2032-12-15","underlying":"Class A Common Stock","underlying_shares":7286},"source":{"system":"sec-edgar","filing":"0000950170-25-024984","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017025024984/ownership.xml","form_type":"4"}},{"id":1252473,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-21T22:17:52.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":18121,"price":83.7519,"value":1517668.1799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $83.41 to $84.19, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 37,290 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":37290,"source":{"system":"sec-edgar","filing":"0000950170-25-024984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017025024984/ownership.xml","form_type":"4"}},{"id":1252472,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2025-02-21T22:17:52.000Z","date":"2025-02-19","kind":"exercise","planned":false,"acquired":true,"shares":7286,"price":71.07,"value":517816.02,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 37,290 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":55411,"source":{"system":"sec-edgar","filing":"0000950170-25-024984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017025024984/ownership.xml","form_type":"4"}},{"id":1326381,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-12-19T02:27:36.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":false,"shares":4593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,527 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 4,593 PSUs. The remaining 1,934 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,527 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 70.37% of the target award amount resulting in the vesting of 4,593 PSUs. The remaining 1,934 PSUs were cancelled. The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":4593},"source":{"system":"sec-edgar","filing":"0000950170-24-138167","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138167/ownership.xml","form_type":"4"}},{"id":1326380,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-19T02:27:36.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":27334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted for a total of 27,334 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2024, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":27334,"derivative":{"exercise_price":77.91,"expiration_date":"2034-12-16","underlying":"Class A Common Stock","underlying_shares":27334},"source":{"system":"sec-edgar","filing":"0000950170-24-138167","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138167/ownership.xml","form_type":"4"}},{"id":1326379,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2024-12-19T02:27:36.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":7775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 16, 2024 and ending December 13, 2027 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":7775,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7775},"source":{"system":"sec-edgar","filing":"0000950170-24-138167","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138167/ownership.xml","form_type":"4"}},{"id":1326378,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-19T02:27:36.000Z","date":"2024-12-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":7712,"price":79.18,"value":610636.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 37,290 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":48125,"source":{"system":"sec-edgar","filing":"0000950170-24-138167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138167/ownership.xml","form_type":"4"}},{"id":1326377,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-19T02:27:36.000Z","date":"2024-12-16","kind":"exercise","planned":false,"acquired":true,"shares":4593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 51,244 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":55837,"source":{"system":"sec-edgar","filing":"0000950170-24-138167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138167/ownership.xml","form_type":"4"}},{"id":1326376,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2024-12-19T02:27:36.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":15550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 15,550 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 16, 2024. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 51,244 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":51244,"source":{"system":"sec-edgar","filing":"0000950170-24-138167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024138167/ownership.xml","form_type":"4"}},{"id":1606559,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-01T21:30:09.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":false,"shares":3523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":3523},"source":{"system":"sec-edgar","filing":"0000950170-24-023922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024023922/ownership.xml","form_type":"4"}},{"id":1606558,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-03-01T21:30:09.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":false,"shares":8499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 29,143 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":20644,"derivative":{"exercise_price":71.07,"expiration_date":"2032-12-15","underlying":"Class A Common Stock","underlying_shares":8499},"source":{"system":"sec-edgar","filing":"0000950170-24-023922","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024023922/ownership.xml","form_type":"4"}},{"id":1606557,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-01T21:30:09.000Z","date":"2024-02-28","kind":"sale","planned":false,"acquired":false,"shares":24395,"price":81.6888,"value":1992798.276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $81.65 to $81.78, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 35,694 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":35694,"source":{"system":"sec-edgar","filing":"0000950170-24-023922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024023922/ownership.xml","form_type":"4"}},{"id":1606556,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-01T21:30:09.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":true,"shares":3523,"price":68.4,"value":240973.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 35,694 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":60089,"source":{"system":"sec-edgar","filing":"0000950170-24-023922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024023922/ownership.xml","form_type":"4"}},{"id":1606555,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-01T21:30:09.000Z","date":"2024-02-28","kind":"exercise","planned":false,"acquired":true,"shares":8499,"price":71.07,"value":604023.93,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 35,694 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":56566,"source":{"system":"sec-edgar","filing":"0000950170-24-023922","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000095017024023922/ownership.xml","form_type":"4"}},{"id":1704495,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2023-12-20T00:33:52.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":false,"shares":5118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,365 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,118 PSUs. The remaining 1,247 PSUs were cancelled.  The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 15, 2020 and ending December 12, 2023. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 6,365 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.41% of the target award amount resulting in the vesting of 5,118 PSUs. The remaining 1,247 PSUs were cancelled.  The service-based vesting component of the PSU award was satisfied upon certification of the achievement of the performance criteria."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5118},"source":{"system":"sec-edgar","filing":"0001209191-23-059259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059259/doc4.xml","form_type":"4"}},{"id":1704494,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-20T00:33:52.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":24262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option was granted for a total of 24,262 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2023, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":24262,"derivative":{"exercise_price":87.49,"expiration_date":"2033-12-15","underlying":"Class A Common Stock","underlying_shares":24262},"source":{"system":"sec-edgar","filing":"0001209191-23-059259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059259/doc4.xml","form_type":"4"}},{"id":1704493,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2023-12-20T00:33:52.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":6921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon (i) achievement of performance criteria measured during a three-year performance period beginning on December 15, 2023 and ending December 10, 2026 and (ii) a service-based vesting component to be satisfied upon certification of the achievement of the performance criteria. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":6921,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6921},"source":{"system":"sec-edgar","filing":"0001209191-23-059259","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059259/doc4.xml","form_type":"4"}},{"id":1704492,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:33:52.000Z","date":"2023-12-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1153,"price":87.49,"value":100875.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 35,694 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":48067,"source":{"system":"sec-edgar","filing":"0001209191-23-059259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059259/doc4.xml","form_type":"4"}},{"id":1704491,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:33:52.000Z","date":"2023-12-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":6716,"price":88.6,"value":595037.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 38,019 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":49220,"source":{"system":"sec-edgar","filing":"0001209191-23-059259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059259/doc4.xml","form_type":"4"}},{"id":1704490,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:33:52.000Z","date":"2023-12-15","kind":"exercise","planned":false,"acquired":true,"shares":5118,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 48,512 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":55936,"source":{"system":"sec-edgar","filing":"0001209191-23-059259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059259/doc4.xml","form_type":"4"}},{"id":1704489,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-12-20T00:33:52.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":13842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Award represents a total of 13,842 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2023. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 48,512 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":50818,"source":{"system":"sec-edgar","filing":"0001209191-23-059259","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123059259/doc4.xml","form_type":"4"}},{"id":1788881,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-09-05T20:56:11.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":false,"shares":5285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":3523,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":5285},"source":{"system":"sec-edgar","filing":"0001209191-23-048187","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123048187/doc4.xml","form_type":"4"}},{"id":1788880,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-05T20:56:11.000Z","date":"2023-08-31","kind":"sale","planned":false,"acquired":false,"shares":6889,"price":84.4092,"value":581494.9788,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $84.39 to $84.415. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":36976,"source":{"system":"sec-edgar","filing":"0001209191-23-048187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123048187/doc4.xml","form_type":"4"}},{"id":1788879,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-09-05T20:56:11.000Z","date":"2023-08-31","kind":"exercise","planned":false,"acquired":true,"shares":5285,"price":68.4,"value":361494.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":43865,"source":{"system":"sec-edgar","filing":"0001209191-23-048187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123048187/doc4.xml","form_type":"4"}},{"id":1992675,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-24T21:09:58.000Z","date":"2023-02-22","kind":"exercise","acquired":false,"shares":7927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":8808,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":7927},"source":{"system":"sec-edgar","filing":"0001209191-23-012679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123012679/doc4.xml","form_type":"4"}},{"id":1992674,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-24T21:09:58.000Z","date":"2023-02-22","kind":"exercise","acquired":false,"shares":5209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 125,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":62.43,"expiration_date":"2028-07-16","underlying":"Class A Common Stock","underlying_shares":5209},"source":{"system":"sec-edgar","filing":"0001209191-23-012679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123012679/doc4.xml","form_type":"4"}},{"id":1992673,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-24T21:09:58.000Z","date":"2023-02-22","kind":"exercise","acquired":false,"shares":5250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 36,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":64.6,"expiration_date":"2028-12-17","underlying":"Class A Common Stock","underlying_shares":5250},"source":{"system":"sec-edgar","filing":"0001209191-23-012679","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123012679/doc4.xml","form_type":"4"}},{"id":1992672,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T21:09:58.000Z","date":"2023-02-22","kind":"sale","acquired":false,"shares":28701,"price":82.3231,"value":2362755.2931,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $81.95 to $82.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":38580,"source":{"system":"sec-edgar","filing":"0001209191-23-012679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123012679/doc4.xml","form_type":"4"}},{"id":1992671,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T21:09:58.000Z","date":"2023-02-22","kind":"exercise","acquired":true,"shares":7927,"price":68.4,"value":542206.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":67281,"source":{"system":"sec-edgar","filing":"0001209191-23-012679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123012679/doc4.xml","form_type":"4"}},{"id":1992670,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T21:09:58.000Z","date":"2023-02-22","kind":"exercise","acquired":true,"shares":5209,"price":62.43,"value":325197.87,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":59354,"source":{"system":"sec-edgar","filing":"0001209191-23-012679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123012679/doc4.xml","form_type":"4"}},{"id":1992669,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T21:09:58.000Z","date":"2023-02-22","kind":"exercise","acquired":true,"shares":5250,"price":64.6,"value":339150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 34,670 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":54145,"source":{"system":"sec-edgar","filing":"0001209191-23-012679","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919123012679/doc4.xml","form_type":"4"}},{"id":2081315,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2022-12-20T02:41:45.000Z","date":"2022-12-16","kind":"exercise","acquired":false,"shares":3765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 4,650 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400\nIndex at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 3,765 PSUs. The remaining 885 PSUs were cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The vesting of the PSU award was dependent upon the achievement of performance criteria measured during a three-year performance period beginning on December 16, 2019 and ending December 13, 2022. The reporting person was eligible to earn from 0% to 200% of the target award amount (which was 4,650 shares) based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400\nIndex at the end of the three-year performance period. Following the end of the three-year performance period, the Issuer's Compensation Committee certified the achievement of the performance criteria at 80.98% of the target award amount resulting in the vesting of 3,765 PSUs. The remaining 885 PSUs were cancelled."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3765},"source":{"system":"sec-edgar","filing":"0001209191-22-062078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062078/doc4.xml","form_type":"4"}},{"id":2081314,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-20T02:41:45.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":29143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted for a total of 29,143 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2022, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":29143,"derivative":{"exercise_price":71.07,"expiration_date":"2032-12-15","underlying":"Class A Common Stock","underlying_shares":29143},"source":{"system":"sec-edgar","filing":"0001209191-22-062078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062078/doc4.xml","form_type":"4"}},{"id":2081313,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2022-12-20T02:41:45.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":8094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2022 and ending December 10, 2025. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":8094,"derivative":{"underlying":"Class A Common Stock","underlying_shares":8094},"source":{"system":"sec-edgar","filing":"0001209191-22-062078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062078/doc4.xml","form_type":"4"}},{"id":2081312,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:41:45.000Z","date":"2022-12-19","kind":"tax_withholding","acquired":false,"shares":1116,"price":70.8,"value":79012.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held following the reported transactions include 34,670 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":48895,"source":{"system":"sec-edgar","filing":"0001209191-22-062078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062078/doc4.xml","form_type":"4"}},{"id":2081311,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:41:45.000Z","date":"2022-12-16","kind":"tax_withholding","acquired":false,"shares":3020,"price":71.07,"value":214631.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Shares held following the reported transactions include 36,920 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":50011,"source":{"system":"sec-edgar","filing":"0001209191-22-062078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062078/doc4.xml","form_type":"4"}},{"id":2081310,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:41:45.000Z","date":"2022-12-16","kind":"exercise","acquired":true,"shares":3765,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held following the reported transactions include 39,245 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":53031,"source":{"system":"sec-edgar","filing":"0001209191-22-062078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062078/doc4.xml","form_type":"4"}},{"id":2081309,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:41:45.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":16188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Award represents a total of 16,188 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2022. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held following the reported transactions include 39,245 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":49266,"source":{"system":"sec-edgar","filing":"0001209191-22-062078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062078/doc4.xml","form_type":"4"}},{"id":2081308,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-12-20T02:41:45.000Z","date":"2022-12-15","kind":"tax_withholding","acquired":false,"shares":3197,"price":73.17,"value":233924.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer in a transaction exempt from Section 16(b) and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units or performance-based restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 23,057 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":33078,"source":{"system":"sec-edgar","filing":"0001209191-22-062078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122062078/doc4.xml","form_type":"4"}},{"id":2205159,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-20T01:35:27.000Z","date":"2022-07-18","kind":"tax_withholding","acquired":false,"shares":1513,"price":73.09,"value":110585.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 29,503 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":36275,"source":{"system":"sec-edgar","filing":"0001209191-22-042658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122042658/doc4.xml","form_type":"4"}},{"id":2261552,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-19","kind":"exercise","acquired":false,"shares":5813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":16735,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":5813},"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261551,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This performance-based stock option award was granted for a total of 18,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 17, 2021 was at 75% of target, or 13,500 shares."}],"balance_after":0,"derivative":{"exercise_price":64.6,"expiration_date":"2025-12-17","underlying":"Class A Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261550,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":2113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":22548,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":2113},"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261549,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":23437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":5209,"derivative":{"exercise_price":62.43,"expiration_date":"2028-07-16","underlying":"Class A Common Stock","underlying_shares":23437},"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261548,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":6750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":5250,"derivative":{"exercise_price":64.6,"expiration_date":"2028-12-17","underlying":"Class A Common Stock","underlying_shares":6750},"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261547,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-19","kind":"sale","acquired":false,"shares":5813,"price":75.8,"value":440625.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The shares were sold in multiple transactions at prices ranging from $75.73 to $75.86, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":37788,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261546,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-19","kind":"exercise","acquired":true,"shares":5813,"price":68.4,"value":397609.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":43601,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261545,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"sale","acquired":false,"shares":13500,"price":75.0216,"value":1012791.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares were sold in multiple transactions at prices ranging from $75.00 to $75.12, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":37788,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261544,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":13500,"price":64.6,"value":872100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":51288,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261543,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"sale","acquired":false,"shares":2113,"price":75.1404,"value":158771.6652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $75.13 to $75.15, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":37788,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261542,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":2113,"price":68.4,"value":144529.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":39901,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261541,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"sale","acquired":false,"shares":23437,"price":75.4685,"value":1768755.2345,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $75.155 to $75.76, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":37788,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261540,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":23437,"price":62.43,"value":1463171.91,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":61225,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261539,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"sale","acquired":false,"shares":6750,"price":75.9371,"value":512575.425,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $75.77 to $76.07, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":37788,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2261538,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-20T20:27:00.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":6750,"price":64.6,"value":436050.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 33,878 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":44538,"source":{"system":"sec-edgar","filing":"0001209191-22-031016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919122031016/doc4.xml","form_type":"4"}},{"id":2463635,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-21T01:39:58.000Z","date":"2021-12-17","kind":"tax_withholding","acquired":false,"shares":1116,"price":92,"value":102672.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 33,878 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":37788,"source":{"system":"sec-edgar","filing":"0001209191-21-070705","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121070705/doc4.xml","form_type":"4"}},{"id":2469598,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-17T02:24:35.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":27020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted for a total of 27,020 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2021, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter."}],"balance_after":27020,"derivative":{"exercise_price":91.8,"expiration_date":"2031-12-15","underlying":"Class A Common Stock","underlying_shares":27020},"source":{"system":"sec-edgar","filing":"0001209191-21-070103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121070103/doc4.xml","form_type":"4"}},{"id":2469597,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Performance-Based Restricted Stock Unit","published_at":"2021-12-17T02:24:35.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":6527,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The vesting of this performance-based restricted stock unit (\"PSU\") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2021 and ending December 11, 2024. Each PSU represents a right to receive, upon vesting, one share of Class A common stock.  The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 200% of the target award amount based on achievement of annualized total shareholder return compared to the S&P Mid Cap 400 Index at the end of the three-year performance period. The actual PSU award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period."}],"balance_after":6527,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6527},"source":{"system":"sec-edgar","filing":"0001209191-21-070103","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121070103/doc4.xml","form_type":"4"}},{"id":2469596,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-17T02:24:35.000Z","date":"2021-12-16","kind":"tax_withholding","acquired":false,"shares":1153,"price":91.8,"value":105845.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Shares held following the reported transactions include 36,128 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":38904,"source":{"system":"sec-edgar","filing":"0001209191-21-070103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121070103/doc4.xml","form_type":"4"}},{"id":2469595,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-17T02:24:35.000Z","date":"2021-12-15","kind":"grant","acquired":true,"shares":13054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Award represents a total of 13,054 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2021. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Shares held following the reported transactions include 38,453 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":40057,"source":{"system":"sec-edgar","filing":"0001209191-21-070103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121070103/doc4.xml","form_type":"4"}},{"id":2469594,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-17T02:24:35.000Z","date":"2021-12-15","kind":"tax_withholding","acquired":false,"shares":1578,"price":90.55,"value":142887.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 25,399 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":27003,"source":{"system":"sec-edgar","filing":"0001209191-21-070103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121070103/doc4.xml","form_type":"4"}},{"id":2584878,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"exercise","acquired":false,"shares":881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":24661,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":881},"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2584877,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"exercise","acquired":false,"shares":2604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":28646,"derivative":{"exercise_price":62.43,"expiration_date":"2028-07-16","underlying":"Class A Common Stock","underlying_shares":2604},"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2584876,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":12000,"derivative":{"exercise_price":64.6,"expiration_date":"2028-12-17","underlying":"Class A Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2584875,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":881,"price":98.62,"value":86884.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":28581,"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2584874,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"exercise","acquired":true,"shares":881,"price":68.4,"value":60260.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":29462,"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2584873,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":2604,"price":98.62,"value":256806.48,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":28581,"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2584872,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"exercise","acquired":true,"shares":2604,"price":62.43,"value":162567.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":31185,"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2584871,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":750,"price":98.62,"value":73965.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":28581,"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2584870,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-01T00:54:31.000Z","date":"2021-08-31","kind":"exercise","acquired":true,"shares":750,"price":64.6,"value":48450.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":29331,"source":{"system":"sec-edgar","filing":"0001209191-21-054179","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121054179/doc4.xml","form_type":"4"}},{"id":2608267,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":4404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":25542,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":4404},"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2608266,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":5653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":31250,"derivative":{"exercise_price":62.43,"expiration_date":"2028-07-16","underlying":"Class A Common Stock","underlying_shares":5653},"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2608265,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":12750,"derivative":{"exercise_price":64.6,"expiration_date":"2028-12-17","underlying":"Class A Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2608264,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":4404,"price":98.1932,"value":432442.8528,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares were sold in multiple transactions at prices ranging from $98.145 to $98.28, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":28581,"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2608263,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":4404,"price":68.4,"value":301233.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":32985,"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2608262,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":5653,"price":98.634,"value":557578.002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $98.28 to $99.10, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":28581,"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2608261,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":5653,"price":62.43,"value":352916.79,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":34234,"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2608260,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":3750,"price":98.0963,"value":367861.125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $98.03 to $98.145, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":28581,"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2608259,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-10T22:13:41.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":3750,"price":64.6,"value":242250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":32331,"source":{"system":"sec-edgar","filing":"0001209191-21-050669","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050669/doc4.xml","form_type":"4"}},{"id":2612737,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-08-05T22:18:09.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":7368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":36903,"derivative":{"exercise_price":62.43,"expiration_date":"2028-07-16","underlying":"Class A Common Stock","underlying_shares":7368},"source":{"system":"sec-edgar","filing":"0001209191-21-050042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050042/doc4.xml","form_type":"4"}},{"id":2612736,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-05T22:18:09.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":7368,"price":100.0114,"value":736883.9952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $100.00 to $100.155, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":28581,"source":{"system":"sec-edgar","filing":"0001209191-21-050042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050042/doc4.xml","form_type":"4"}},{"id":2612735,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-05T22:18:09.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":7368,"price":62.43,"value":459984.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":35949,"source":{"system":"sec-edgar","filing":"0001209191-21-050042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050042/doc4.xml","form_type":"4"}},{"id":2612734,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-08-05T22:18:09.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":2746,"price":100.1013,"value":274878.1698,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $100.115 to $100.22, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":28581,"source":{"system":"sec-edgar","filing":"0001209191-21-050042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121050042/doc4.xml","form_type":"4"}},{"id":2631788,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-07-16T20:40:58.000Z","date":"2021-07-16","kind":"tax_withholding","acquired":false,"shares":1629,"price":99.82,"value":162606.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incident to the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held following the reported transactions include 28,581 restricted stock units, which are subject to forfeiture until they vest."}],"balance_after":31327,"source":{"system":"sec-edgar","filing":"0001209191-21-046941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121046941/doc4.xml","form_type":"4"}},{"id":2835352,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-24T21:20:19.000Z","date":"2021-02-23","kind":"exercise","acquired":false,"shares":10229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":29946,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":10229},"source":{"system":"sec-edgar","filing":"0001209191-21-013776","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121013776/doc4.xml","form_type":"4"}},{"id":2835351,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-02-24T21:20:19.000Z","date":"2021-02-23","kind":"sale","acquired":false,"shares":10229,"price":95.0871,"value":972645.9459,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple transactions at prices ranging from $95.05 to $95.30, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":32956,"source":{"system":"sec-edgar","filing":"0001209191-21-013776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121013776/doc4.xml","form_type":"4"}},{"id":2835350,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-02-24T21:20:19.000Z","date":"2021-02-23","kind":"exercise","acquired":true,"shares":10229,"price":68.4,"value":699663.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":43185,"source":{"system":"sec-edgar","filing":"0001209191-21-013776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121013776/doc4.xml","form_type":"4"}},{"id":2842914,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-23T01:48:17.000Z","date":"2021-02-19","kind":"exercise","acquired":false,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option was granted for a total of 42,275 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares vest in equal monthly installments over the next 36 months thereafter."}],"balance_after":40175,"derivative":{"exercise_price":68.4,"expiration_date":"2029-12-16","underlying":"Class A Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001209191-21-013012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121013012/doc4.xml","form_type":"4"}},{"id":2842913,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-23T01:48:17.000Z","date":"2021-02-19","kind":"exercise","acquired":false,"shares":7813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted for a total of 125,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of July 16, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":44271,"derivative":{"exercise_price":62.43,"expiration_date":"2028-07-16","underlying":"Class A Common Stock","underlying_shares":7813},"source":{"system":"sec-edgar","filing":"0001209191-21-013012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121013012/doc4.xml","form_type":"4"}},{"id":2842912,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-23T01:48:17.000Z","date":"2021-02-19","kind":"exercise","acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted for a total of 36,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter."}],"balance_after":16500,"derivative":{"exercise_price":64.6,"expiration_date":"2028-12-17","underlying":"Class A Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001209191-21-013012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121013012/doc4.xml","form_type":"4"}},{"id":2842911,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-02-23T01:48:17.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":2306,"price":94.1261,"value":217054.7866,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":32956,"source":{"system":"sec-edgar","filing":"0001209191-21-013012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121013012/doc4.xml","form_type":"4"}},{"id":2842910,"issuer":{"id":2518,"kind":"organization","name":"Dolby Laboratories, Inc.","symbol":"DLB"},"owners":[{"id":43774,"kind":"person","name":"Pendleton Todd","position":1,"cik":"0001746636","reported_name":"Pendleton Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Marketing Officer"}}],"security":"Class A Common Stock","published_at":"2021-02-23T01:48:17.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":2100,"price":94.0061,"value":197412.81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in multiple transactions at prices ranging from $94.00 to $94.02, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares held following the reported transactions include 32,956 restricted stock units, which are subject to forfeiture until they vest"}],"balance_after":35262,"source":{"system":"sec-edgar","filing":"0001209191-21-013012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1308547/000120919121013012/doc4.xml","form_type":"4"}}],"next_cursor":"2021-02-23T01:48:17.000000Z,2842910"}